Search Results - "Gagloeva, D. A."

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation by Zelberg, M. A., Mironov, N. Yu, Dzaurova, Kh. M., Yuricheva, Yu. A., Maykov, E. B., Novikov, P. S., Gagloeva, D. A., Krimukova, M. A., Sokolov, S. F., Golitsyn, S. P.

“…Objective. Evaluate efficacy and safety of cavutilide (Refralon) for pharmacological cardioversion in patients with recurrent atrial fibrillation and flutter…”
Get full text

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter by Gagloeva, D. A., Dzaurova, Kh. M., Zelberg, M. A., Mironov, N. Yu, Yuricheva, Yu. A., Sokolov, S. F., Krymukova, M. A., Salpagarova, A. I., Dulaev, L. O., Pevzner, D. V., Golitsyn, S. P.

“…Aim . To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibril­lation and…”
Get full text

Results of a prospective randomized study comparing efficacy and safety of refralon and amiodarone for cardioversion in patients with paroxysmal atrial fibrillation and flutter by Gagloeva, D. A., Mironov, N. Yu, Dzaurova, Kh. M., Zelberg, M. A., Yuricheva, Yu. A., Sokolov, S. F., Golitsyn, S. P.

“…Aim . To compare efficacy and safety of refralon and amiodarone for cardioversion in patients with paroxysmal atrial fibrillation and flutter (AF/AFL).  …”
Get full text